-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
HCW Biologics Inc. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Dec 2020 to 31 Mar 2025.
- HCW Biologics Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $3,513,856, a 2.5% increase year-over-year.
- HCW Biologics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $14,227,428, a 37% increase from 2023.
- HCW Biologics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $22,514,121, a 117% decline from 2022.
- HCW Biologics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $10,386,110, a 5.4% increase from 2021.